Dutch healthcare system and reimbursement procedures knowledge
Zin, ciebag, gvs regulatory pathway expertise
This newly created strategic position leads the launch of a new cardiovascular drug in 2028 while managing the broader non-oncology portfolio
Job Summary
This newly created strategic position leads the launch of a new cardiovascular drug in 2028 while managing the broader non-oncology portfolio.
The role requires designing comprehensive patient access plans and navigating complex reimbursement processes with key stakeholders like ZIN and the Ministry of Health.
Candidates will receive competitive benefits including a company car, 35.5 days of leave, and a solid pension plan within a global dynamic environment.
Matching Summary
This newly created strategic position leads the launch of a new cardiovascular drug in 2028 while managing the broader non-oncology portfolio.
Salary
Competitive salary; 3% year-end bonus; Incentive Plan included
Skills & Requirements
Must-have
7+ years pharmaceutical market access experience
Dutch healthcare system and reimbursement procedures knowledge
ZIN, cieBAG, GVS regulatory pathway expertise
Health economics and HTA analysis skills
Cross-functional team functional leadership
Nice-to-have
Strong strategic thinking and analytical skills
Excellent negotiation and relationship building
Experience with cardiovascular or non-oncology portfolios
Fluency in Dutch and English languages
Key Requirements
University degree in health economics, pharmacy, or life sciences
Minimum 7 years of experience as a market access manager or lead
Proven ability to navigate Dutch reimbursement dossiers and GVS procedures